Martingale Asset Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-485
| Closed | -$39.9K | – | 826 |
|
|
2023
Q2 | $39.9K | Buy |
485
+1
| +0.2% | +$82 | ﹤0.01% | 794 |
|
|
2023
Q1 | $49.8K | Hold |
484
| – | – | ﹤0.01% | 814 |
|
|
2022
Q4 | $71K | Hold |
484
| – | – | ﹤0.01% | 819 |
|
|
2022
Q3 | $82K | Hold |
484
| – | – | ﹤0.01% | 810 |
|
|
2022
Q2 | $56K | Buy |
484
+2
| +0.4% | +$231 | ﹤0.01% | 837 |
|
|
2022
Q1 | $49K | Hold |
482
| – | – | ﹤0.01% | 798 |
|
|
2021
Q4 | $75K | Buy |
+482
| New | +$75K | ﹤0.01% | 811 |
|